{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:23:56Z","timestamp":1773285836163,"version":"3.50.1"},"reference-count":33,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1253\/circj.cj-10-0013","type":"journal-article","created":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T02:30:20Z","timestamp":1275359420000},"page":"1471-1478","source":"Crossref","is-referenced-by-count":35,"title":["Single Administration of α-Glucosidase Inhibitors on Endothelial Function and Incretin Secretion in Diabetic Patients With Coronary Artery Disease"],"prefix":"10.1253","volume":"74","author":[{"given":"Makoto","family":"Hiki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kiyanagi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Fukao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Ohsaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsumi","family":"Kume","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Matsumori","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Sumiyoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Ohmura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kurata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miida","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: Meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73-78.","DOI":"10.1136\/bmj.38678.389583.7C"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hayashi T, Kawashima S, Itoh H, Yamada N, Sone H, Watanabe H, et al; Japan CDM group. Importance of lipid levels in elderly diabetic individuals: Baseline characteristics and 1-year survey of cardiovascular events. Circ J 2008; 72: 218-225.","DOI":"10.1253\/circj.72.218"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.","DOI":"10.1056\/NEJM199807233390404"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000; 23: 1830-1834.","DOI":"10.2337\/diacare.23.12.1830"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Azuma K, Kawamori R, Toyofuku Y, Kitahara Y, Sato F, Shimizu T, et al. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 2006; 26: 2275-2780.","DOI":"10.1161\/01.ATV.0000239488.05069.03"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mita T, Otsuka A, Azuma K, Uchida T, Ogihara T, Fujitani Y, et al. Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun 2007; 358: 679-685.","DOI":"10.1016\/j.bbrc.2007.04.118"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Iijima R, Nakajima R, Sugi K, Nakamura M. Improvement of postprandial hyperglycemia has a positive impact on epicardial flow of entire coronary tree in acute coronary syndromes patients. Circ J 2007; 71: 1079-1085.","DOI":"10.1253\/circj.71.1079"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Miyazaki T, Shimada K, Iwama Y, Kume A, Sumiyoshi K, Sato Y, et al. Insulin response to oral glucose load is associated with coronary artery disease in subjects with normal glucose tolerance. J Atheroscler Thromb 2008; 15: 6-12.","DOI":"10.5551\/jat.E515"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. DECODE Study Group. Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.","DOI":"10.1001\/archinte.161.3.397"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, et al. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: The DECODA study. Eur J Cardiovasc Prev Rehabil 2006; 13: 555-561.","DOI":"10.1097\/01.hjr.0000183916.28354.69"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet 2002; 359: 2072-2077.","DOI":"10.1016\/S0140-6736(02)08905-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOP-NIDDM trial. JAMA 2003; 290: 486-494.","DOI":"10.1001\/jama.290.4.486"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Meta-analysis of seven long-term studies. Eur Heart J 2004; 25: 10-16.","DOI":"10.1016\/S0195-668X(03)00468-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Glass CK, Witztum JL. Atherosclerosis: The road ahead. Cell 2001; 104: 503-516.","DOI":"10.1016\/S0092-8674(01)00238-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196.","DOI":"10.1161\/01.CIR.104.2.191"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Vanhoutte PM. Endothelial dysfunction: The first step toward coronary arteriosclerosis. Circ J 2009; 73: 595-601.","DOI":"10.1253\/circj.CJ-08-1169"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57: 1349-1354.","DOI":"10.2337\/db08-0063"},{"key":"18","unstructured":"18. Ahr HJ, Boberg M, Brendel E, Krause HP, Steinke W. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. Arzneimittelforschung 1997; 47: 734-745."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mita T, Otsuka A, Azuma K, Uchida T, Ogihara T, Fujitani Y, et al. Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun 2007; 358: 679-685.","DOI":"10.1016\/j.bbrc.2007.04.118"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 2001; 50: 609-613.","DOI":"10.2337\/diabetes.50.3.609"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nyström T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahrén B, et al. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab 2004; 287: E1209-E1215.","DOI":"10.1152\/ajpendo.00237.2004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Arakawa M, Ebato C, Mita T, Fujitani Y, Shimizu T, Watada H, et al. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects. Metabolism 2008; 57: 1299-1306.","DOI":"10.1016\/j.metabol.2008.04.027"},{"key":"23","unstructured":"23. Yoshino G, Hirano T, Shiba T, Kashiwagi A, Tanaka A, Tada N, et al. The test meal A: A pilot model for the international standard of test meal for an assessment of both postprandial hyperglycemia and hyperlipidemia. J Jpn Diabetes Soc 2006; 49: 361-371 (in Japanese)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Miida T, Nakamura Y, Mezaki T, Hanyu O, Maruyama S, Horikawa Y, et al. LDL-cholesterol and HDL-cholesterol concentrations decrease during the day. Ann Clin Biochem 2002; 39: 241-249.","DOI":"10.1258\/0004563021901946"},{"key":"25","unstructured":"25. Kiyanagi T, Miyazaki T, Kume A, Sumiyoshi K, Hiki M, Ohmura H, et al. Beneficial effects of Telmisartan on lipoprotein profiles and endothelial function in patients with hypertension. Prog Med 2007; 27: 1643-1650."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Arao K, Yasu T, Umemoto T, Jinbo S, Ikeda N, Ueda S, et al. Effects of pitavastatin on fasting and postprandial endothelial function and blood rheology in patients with stable coronary artery disease. Circ J 2009; 73: 1523-1530.","DOI":"10.1253\/circj.CJ-08-0917"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ishibashi Y, Takahashi N, Shimada T, Sugamori T, Sakane T, Umeno T, et al. Short duration of reactive hyperemia in the forearm of subjects with multiple cardiovascular risk factors. Circ J 2006; 70: 115-123.","DOI":"10.1253\/circj.70.115"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: A randomized crossover study. J Clin Endocrinol Metab 2006; 91: 837-842.","DOI":"10.1210\/jc.2005-1566"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Lee A, Patrick P, Wishart J, Horowitz M, Morley JE. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab 2002; 4: 329-335.","DOI":"10.1046\/j.1463-1326.2002.00219.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Narita T, Katsuura Y, Sato T, Hosoba M, Fujita H, Morii T, et al. Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese Type 2 diabetic patients. Diabet Med 2009; 26: 187-188.","DOI":"10.1111\/j.1464-5491.2008.02651.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Scott LJ, Spencer CM. Miglitol: A review of its therapeutic potential in type 2 diabetes mellitus. Drugs 2000; 59: 521-549.","DOI":"10.2165\/00003495-200059030-00012"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002; 8: 738-742.","DOI":"10.1038\/nm727"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kirma C, Akcakoyun M, Esen AM, Barutcu I, Karakaya O, Saglam M, et al. Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circ J 2007; 71: 698-702.","DOI":"10.1253\/circj.71.698"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/74\/7\/74_CJ-10-0013\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T18:18:22Z","timestamp":1559153902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/74\/7\/74_CJ-10-0013\/_article"}},"subtitle":["– Juntendo University Trial: Effects of Miglitol on Endothelial Vascular Reactivity in Type 2 Diabetic Patients With Coronary Heart Disease (J-MACH) –"],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-10-0013","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}